Zobrazeno 1 - 10
of 52
pro vyhledávání: '"ferric pyrophosphate citrate"'
Publikováno v:
The Journal of Clinical Pharmacology. 62:681-688
Ferric pyrophosphate citrate (FPC) is indicated to maintain hemoglobin in patients with stage 5 hemodialysis-dependent chronic kidney disease on chronic hemodialysis by addition to the dialysate. An intravenous (IV) FPC presentation containing 6.75 m
Autor:
Naveed Masani, Shan Wang, Louis Dellafera, Brian Malone, Meredith Akerman, Paula Dutka, Lameesa Dhanani
Publikováno v:
Hosp Pharm
Dialysis patients are often iron deficient due to a multiple factors. Ferric pyrophosphate citrate is a complex iron salt that can be given via dialysate allowing maintenance of hemoglobin (Hgb) concentration and iron balance while reducing the need
Publikováno v:
Archives of Clinical Nephrology. :044-049
Retrospective observational analysis of ferric pyrophosphate citrate (triferic®) administered via dialysate. Experience at a single facility over 2 years
Publikováno v:
Biometals
Iron deficiency is a significant health problem across the world. While many patients benefit from oral iron supplements, some, including those on hemodialysis require intravenous iron therapy to maintain adequate iron levels. Until recently, all iro
Publikováno v:
Biometals
There are several options available for intravenous application of iron supplements, but they all have a similar structure:—an iron core surrounded by a carbohydrate coating. These nanoparticles require processing by the reticuloendothelial system
Publikováno v:
Pediatric Nephrology (Berlin, Germany)
Background Iron deficiency is a common cause of anemia in pediatric patients with hemodialysis-dependent chronic kidney disease (CKD-5HD). Ferric pyrophosphate citrate (FPC, Triferic®) donates iron directly to transferrin, bypassing the reticuloendo
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Critical Care Medicine. 49:551-551
Publikováno v:
Clinical Therapeutics. 38:2318-2323
Purpose The objective of this short review is to evaluate the efficacy of ferric pyrophosphate citrate and to determine its place in therapy based on the current published literature. Methods A literature search was conducted and pared down to yield
Autor:
Iain C. Macdougall
Publikováno v:
Kidney International
Ferric pyrophosphate citrate (FPC) is a water-soluble iron salt administered via dialysate to supply iron directly to transferrin. The PRIME study tested whether treatment with FPC could reduce prescribed erythropoiesis-stimulating agent (ESA) use an